Abnormal phosphorylation of human LRH1 at Ser510 predicts poor prognosis and promotes cell viability in lung squamous cell carcinoma
2025 · BMC Cancer · 1 citations
https://doi.org/10.1186/s12885-025-14160-6
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
105
Papers
1.5K
Citations
23
h-index
35
i10-index
Hironori Takagi is an academic researcher from Fukushima Medical University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Lung Cancer Research Studies. The author has an h-index of 23, co-authored 90 publications.
ORCID: 0000-0001-5438-2479Click to start Chat